Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Raute Corporation - Manager's transactions – Halttunen Ville

Raute Corporation, Manager’s transactions, May 7, 2024, at 9:00 a.m. Raute Corporation – Manager’s transactions – Halttunen Ville ____________________________________________ Person subject to the notification requirement Name: Ville Halttunen Position: Chief Financial Officer Issuer: Raute Oyj LEI: 743700G00629V99PE435 Notification type: INITIAL NOTIFICATION Reference number: 61671/4/4 ____________________________________________ Transaction date: 2024-05-06 Venue: NASDAQ HELSINKI LTD (XHEL) Instrument type: SHARE ISIN: FI0009004741 Nature of

BlueNord: Preliminary Production for April 2024

Oslo, 7 May 2024: BlueNord ASA ("BlueNord" or the "Company") has today announced its preliminary production figures for April 2024. The Company had a preliminary production in April of net 25.5 mboepd. The operational performance for the Dan and Halfdan hubs was strong with preliminary operational efficiency above 90 %. Production on Gorm was temporarily closed in at the end of the month due to planned maintenance on the gas module. This information is subject to disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act and requirements under the EU

AstraZeneca completes Cellectis equity investment

7 May 2024 AstraZeneca completes equity investment agreement with Cellectis AstraZeneca today announced the successful completion of an equity investment with Cellectis, a clinical-stage biotechnology company. The equity investment and a research collaboration agreement, announced in November 2023  will leverage the Cellectis proprietary gene editing technologies and manufacturing capabilities, to design up to 10 novel cell and gene therapy products for areas of

Flexion and Jam City Partner to Expand Publishing to Alternative App Stores

LONDON – 7 May 2024 - Flexion ( NASDAQ:FLEXM.ST), the games marketing company, has partnered with Jam City, a leading mobile entertainment company behind some of the world’s highest-grossing and most enduring mobile games, to bring a selection of the publisher’s best-in-class games to the Alternative App Stores: Amazon Appstore, Huawei App Gallery, Aptoide, ONE store, Samsung Galaxy Store, DT Hub, and Xiaomi GetApps. “We are always looking for new opportunities to build our network of global players, and Flexion is a proven partner that will help introduce our award-winning titles to new

Fortum to pilot hydrogen production in Loviisa

FORTUM CORPORATION PRESS RELEASE 7.5.2024Fortum will build a hydrogen production pilot plant in Loviisa. The plant will be located in the Källa area near Fortum’s Loviisa nuclear power plant on a plot owned by the company. The construction of the Kalla test center will begin in the summer of 2024, and the plant is scheduled to be commissioned in late 2025.   Hydrogen will be produced by electrolysers, by using electricity to split water into hydrogen and oxygen, with a capacity of around two megawatts from the main grid and using local household water in Loviisa. A filling station will

Metso has delivered 100 truck bodies to date – most recently to Boliden Kevitsa in Finland

Metso Corporation’s press release on May 7, at 9:00 a.m. EESTMetso is celebrating the milestone delivery of its 100[th] truck body; the delivery went to Boliden’s Kevitsa mine in the Sodankylä region in Finland. Truck bodies belong to Metso’s portfolio of comprehensive payload management solutions. This portfolio enables Metso to assist its mining and aggregates customers in optimizing their loading and hauling capability, minimizing the environmental impact, and maximizing utilization of the loaders and haul truck bodies. Metso’s range of payload management solutions was considerably

Danske Bank invests in United Fintech and joins board to digitally support its Forward ’28 strategy

Joining United Fintech’s circle of institutional investors, Danske Bank takes a seat at the board of a leading industry-neutral Digital Transformation Platform alongside BNP Paribas and Citi to support the bank’s Forward ’28 strategy from a digital frontier. A move signalling that shared collaboration is the way ahead for financial services as global banking enters a new era of collective innovation.   Danske Bank A/S has become the third institutional investor in United Fintech Group Limited securing the Nordic bank a rotating board seat in the rapidly growing industry-neutral

Remedy Entertainment Plc: Codename Kestrel cancelled as Remedy focuses on existing franchises

Remedy Entertainment Plc      Press Release      May 7, 2024, at 9.00 a.m. EESTCodename Kestrel cancelled as Remedy focuses on existing franchises Remedy Entertainment Plc (“Remedy”) and Tencent Plc (“Tencent”) have decided to cancel the game project codename Kestrel. Codename Kestrel had a small team working on the early concept stage of a premium cooperative multiplayer game. The game was being developed by Remedy, co-financed with Tencent, and to be co-published with Tencent. The project started in November 2023 as a reboot from an earlier project codenamed Vanguard. The decision

BioGaia AB: Interim Management Statement January – March 2024

FIRST QUARTER 2024(For balance sheet items, figures in parentheses refer to year-end 2023 figures. For income statement and cash flow items, they refer to the same period last year). Net sales amounted to SEK 369.8 million (365.8), an increase of SEK 4.0 million, or 1% (excluding foreign exchange effects, 2%). Net sales in the Pediatrics segment amounted to SEK 292.3 million (306.0), a decrease of 4% (excluding foreign exchange effects a decrease of 4%). Net sales in the Adult Health segment amounted to SEK 74.8 million (56.6), an increase of 32% (excluding foreign exchange

Interim report 1 January – 31 March 2024

Stable earnings and a focus on accelerating projects to the divestment phase CEO comment: We are now wrapping up an intense first quarter with good progress in all markets in terms of project development and stable, favourable production revenue in line with our expectations with a positive contribution from price hedging. The company is now in its next phase, where we will deliver projects for sale at a higher frequency. We are focusing on accelerating projects to the divestment phase and thereby delivering on our targets of a total of 400 MW in 2024–2025 and 500 MW annually

Archer Limited: Ex. reverse share split today

Hamilton, Bermuda (May 7, 2024) Reference is made to the key date announcement published on 3 May 2024. The shares in Archer Limited trade ex the reverse share split today. Issuer name: Archer Limited Ex. date: May 7, 2024 Type of corporate action: reverse share split Other information: · Reverse split ratio; twenty-five (25) old shares give one (1) new share. · New par value; USD 0.25 per share · New ISIN: BMG0451H2087. For additional information please contact: Espen Joranger, Chief Financial Officer | Mobile: +47 982 06 812 | Email: espen.joranger@

Regenerative forestry is progressing rapidly – the Metsä Group Plus management model used in around half of all wood trades in February–April

Finnish forest owners have enthusiastically welcomed the measures implementing Metsä Group’s regenerative forestry principles. Of wood trades completed during Metsä Group’s campaign in February–April 2024, approximately 40 per cent were agreed in accordance with the Metsä Group Plus management model. In terms of cubic volume of wood trades, the share was over 50 per cent during the campaign. Metsä Group’s parent company Metsäliitto Cooperative is owned by more than 90,000 Finnish forest-owners, who own around half of Finland’s private forests. The measures we carry out jointly with forest-

Gaming Innovation Group reports Q1 2024

Highlights · Reported revenues (GiG Media) at all-time high of €28.0m (18.4), an increase of 52% (21% organic), with an EBITDA of €13.5 (8.0) · The group, including Platform & Sportsbook achieved all-time high revenues amounting to €36.2m (28.4), an increase of 28% YoY · FTDs for GiG Media were 125,100 (110.800), up 13% YoY · AskGamblers continued positive momentum, with record traffic, players generated, revenue and EBITDA   · Platform & Sportsbook signed eight new agreements and HoTs in Q1-24, and ten brands went live so far in 2024 · Existing customers on the platform

Tero Tynkkynen appointed Chief Commercial Officer for Fazer Group

Tero Tynkkynen (b. 1969) has been appointed Chief Commercial Officer (CCO) for Fazer Group and member of the Fazer Leadership Team. Tero has held the interim CCO position since 1 March 2024, and has demonstrated commendable leadership in steering the newly established Group Commercial Organisation.Tero Tynkkynen joined Fazer from Futuoffice Oy, where he served as Senior Vice President of Business Development. Prior to that, he had a long career at both Amer Sports and Procter & Gamble, where he held various executive leadership positions. "I am delighted to appoint Tero Chief Commercial

Finnair Traffic Performance in April 2024

Finnair Plc                 Investor News              7 May 2024 at 9:00 a.m. EETNumber of passengers increased year-on-year, also cargo figures improvedIn April, Finnair carried 905,200 passengers. This was 4.2% more than in April 2023. The overall capacity, measured in Available Seat Kilometres (ASK), increased in April by 3.9% year-on-year as additional narrow-body capacity was deployed by Finnair after the wet lease outs to British Airways ended in March 2024. If wet lease outs are included, capacity increased by 5.9% due to the co-operation with Qantas. Finnair's traffic,

Interim Report, January - March 2023

Continued growth in the service business and increased profitabilityJanuary - March 2024 · Revenues decreased by 2.4 per cent to SEK 1,191.3 million (1,220.3).  · Adjusted EBITA increased by 66.4 per cent and amounted to SEK 94.5 million (56.8), corresponding to an adjusted EBITA margin of 7.9 per cent (4.7).  · Earnings before tax amounted to SEK 76.2 million (37.3). · Earnings after tax amounted to SEK 60.7 million (27.9). · Earnings per share amounted to SEK 2.22 (1.02). · New contracts relating to cloud services worth SEK 182.7 million (116.6) were contracted, an

Nordic Mining ASA (EN Expand:NOM): Interim report per 31 March 2024

Please find enclosed Nordic Mining’s interim report and company presentation for the first quarter of 2024. The interim report and company update will be presented digitally today, Tuesday 7 May 2024 at 10.00 (CET). The presentation and Q&A session will be held in English and transferred via webcast. You will have the opportunity to post questions online throughout the webcast session. The webcast will be available on: https://channel.royalcast.com/landingpage/hegnarmedia/20240507_4/ Summary of important events in the first quarter of 2024: ·The Company reported NOK 543.2 million

poLight ASA: Last day of the Subscription Period in the Rights Issue

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN CANADA, JAPAN, AUSTRALIA OR THE UNITED STATES, OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN.Reference is made to previous stock exchange announcements from poLight ASA ("poLight" or the "Company") regarding the Company's partially underwritten rights issue of minimum 56,313,623 new shares and maximum 69,305,075 new shares (the "Offer Shares"), to raise gross proceeds of up to NOK

Bladder Cancer: Long-Term Benefits of Blue Light Cystoscopy and Enhanced Detection with HD Technology Unveiled at AUA 2024

Press Release – Oslo, Norway, May 7, 2024: Photocure ASA (OSE: PHO), the Bladder Cancer Company, announces its participation in the congress, and two abstract presentations at the AUA 2024: the American Urological Association Annual Congress 2024 was held May 3-6, 2024, in San Antonio, TX, USA. The results of the BRAVO study performed within the VA healthcare system showed significant decreases in the risk of recurrence and progression, as well as the potential for improved overall survival in patients who received a blue light cystoscopy (BLC[®]) compared to patients whose cystoscopy was

Moberg Pharma´s interim report January - March 2024

LAUNCH INITIATED IN SWEDENFIRST QUARTER (JAN-MAR 2024) · Net revenue SEK 0.8 million (0) · EBITDA SEK -7.6 million (-6.1) · Operating profit (EBIT) SEK -7.9 million (-6.7) · Profit after tax SEK -6.5 million (-5.0) · Diluted earnings per share SEK -0.23 (-0.51) · Cash and cash equivalents amounted to 38.6 million (84.5) SIGNIFICANT EVENTS IN THE FIRST QUARTER · The sale of MOB-015 in Sweden under the brand name Terclara® has begun in collaboration with the company’s partner Allderma and the majority of pharmacies around the country have decided to sell the

Notice of the extra general meeting in Misen Energy AB (publ)

The shareholders of Misen Energy AB (publ), reg. no. 556526-3968, (the “Company”) are hereby invited to the extra general meeting to be held on Tuesday, 28 May 2024 at 9 a.m. at Baker McKenzie's office at Vasagatan 7 in Stockholm. Right to attend the extra general meeting Shareholders who wish to participate in the general meeting must: i. on the record date, which is Monday 20 May 2024, be registered in the share register maintained by Euroclear Sweden AB; andii. no later than on Wednesday 22 May 2024 notify the Company of their and any counsel's participation at the general

Optomed Plc: Interim Report, January – March 2024

Optomed Plc Stock Exchange Release 7 May 2024 at 9.00, Helsinki   Optomed Plc: Interim Report, January – March 2024   January – March 2024   · Revenue decreased by 4.4 percent to EUR 3.3 (3.5) million. · Devices segment revenue increased by 0.1 percent to EUR 0.9 (0.9) million. · Software segment revenue decreased by 5.9 percent to EUR 2.4 (2.6) million. · EBITDA and adjusted EBITDA amounted to EUR -0.6 (-0.5) million corresponding to -26.3 (-14.8) percent of revenue. · Outlook unchanged: Optomed expects its full year 2024 revenue to grow compared to 2023.

There are no items matching the current filter
There are no more items matching the current filter
Back to top